Industry leaders say annual screenings for service members could improve troop readiness, expand diagnosis of hypogonadism and treatment.
Browsing: testosterone replacement therapy
Shah, whose company developed the oral testosterone drug Kyzatrex, urged regulators to broaden treatment access and align policy with modern science and preventive healthcare goals.
Marius Pharmaceuticals, which helped secure FDA removal of Black Box Warning, says regulatory shift marks a milestone for patient access and treatment options.